Regent Pacific Group Ltd. (RPGLF)
0.125
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 36.48M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 25.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 31.49 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.98% |
Profile
| Regent Pacific Group Ltd. is an investment holding company, which engages in investments in biopharma companies, resources, and other corporate investments. It operates through Biopharma and Corporate Investment segments. The Biopharma manages research, development, manufacturing, marketing, and sales of pharmaceutical products. The Corporate Investment segment offers investment in corporate entities, both listed and unlisted. The company was founded by James Mellon and Jayne Allison Sutcliffe in 1990 and is headquartered in Hong Kong. |
| URL | http://www.regentpac.com |
| Investor Relations URL | https://endurancegroup.com/investor-relations |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 08, 2013 |
Profile
| Regent Pacific Group Ltd. is an investment holding company, which engages in investments in biopharma companies, resources, and other corporate investments. It operates through Biopharma and Corporate Investment segments. The Biopharma manages research, development, manufacturing, marketing, and sales of pharmaceutical products. The Corporate Investment segment offers investment in corporate entities, both listed and unlisted. The company was founded by James Mellon and Jayne Allison Sutcliffe in 1990 and is headquartered in Hong Kong. |
| URL | http://www.regentpac.com |
| Investor Relations URL | https://endurancegroup.com/investor-relations |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 08, 2013 |